castle biosciences stock buy or sell
However you should decide whether Castle Biosciences Inc stock is a buy sell or hold based on a combination of grades metrics ratios and US. Is currently rated as a Zacks Rank 3 and we are expecting an inline return.
Castle Biosciences Crunchbase Company Profile Funding
Get the latest Castle Biosciences Inc CSTL detailed stock quotes stock data Real-Time ECN charts stats and more.
. What type of owners hold Castle Biosciences Inc stock. CSTL stock price news buy or sell recommendation and investing advice from Wall Street professionals. Name Hold Shares Value Type.
October 12 2022. Type sellbuy option MAETZOLD. Castle Biosciences to Present Data Supporting the Clinical Value of Its Suite of Skin Cancer Tests through Multiple Oral Presentations at the 2022.
The 7 analysts offering 12-month price forecasts for Castle Biosciences Inc have a median target of 4800 with a high estimate of 6500 and a low estimate of 4000. The average Castle Biosciences stock price prediction forecasts a potential upside of 10514 from the current CSTL share price of 2608. Get the latest Castle Biosciences stock price and detailed information including CSTL news historical charts and realtime prices.
These stocks are the. Castle Biosciences Inc. Get the latest Castle Biosciences Inc.
Zacks proprietary data indicates that Castle Biosciences Inc. Common Stock CSTL Stock Quotes - Nasdaq offers stock quotes market activity data for US and global markets. Check out the forecast and prediction here.
Historical Stock Quote. CSTL stock returns are also predicted based on historical data. Castle Biosciences Insider Transactions Over The Last Year In the last twelve months the biggest single sale by an insider was when the Chief Business Officer Bernhard.
What analysts think CSTL stock price will be. A-RATED STOCKS are those stocks the Big Data multi-factor models score as most probable to rise in price. Is Castle Biosciences Inc NASDAQCSTL stock a buy or a sell.
5 Wall Street research analysts have issued buy hold and sell ratings for Castle Biosciences in the last twelve months. What is CSTLs Earnings Per Share EPS forecast. There are currently 5 buy ratings for the stock.
Castle Biosciences Inc CSTL Exchange. Amount Start Date. 2420 042 179.
Castle Biosciences Ipo The Buying Opportunity Starts At 3x 3 5x Sales Nasdaq Cstl Seeking Alpha
Post Ipo Review Castle Biosciences Grows Despite Pandemic S Effects Ipos On Thestreet U S Ipo Research Opinion
Castle Biosciences Cstl Investor Presentation Slideshow Nasdaq Cstl Seeking Alpha
Omics Tools And Mdx Stocks Down Across The Board In April Following Broader Market Genomeweb
Cathie Wood 11 Castle Biosciences Transactions Ark Invest Cstl
Castle Biosciences Stock An Outperform Candidate
Castle Biosciences Ipo The Buying Opportunity Starts At 3x 3 5x Sales Nasdaq Cstl Seeking Alpha
Alexander Fleming Price Forecasting Models For Castle Biosciences Inc Cstl Stock Paperback Walmart Com
Cstl Stock Price And Chart Nasdaq Cstl Tradingview
Post Ipo Review Castle Biosciences Grows Despite Pandemic S Effects Ipos On Thestreet U S Ipo Research Opinion
Analysts Start Castle Biosciences At Buy And Op With Pts Of 25 To 28 Biotuesdays
What Is The Current Price Target And Forecast For Castle Biosciences Cstl
Cstl Stock Price And Chart Nasdaq Cstl Tradingview
Castle Biosciences Stock Nasdaq Cstl Quotes And News Summary Benzinga
Castle Biosciences Ipo The Buying Opportunity Starts At 3x 3 5x Sales Nasdaq Cstl Seeking Alpha
Zrcbmqxeg5fs0m
Cstl Stock Price And Chart Nasdaq Cstl Tradingview
Arkg Holdings Of Castle Biosciences Cstl Updated Daily
Castle Biosciences Ipo The Buying Opportunity Starts At 3x 3 5x Sales Nasdaq Cstl Seeking Alpha